{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:26:55Z","timestamp":1762432015481},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Infrared monitor-guided bleb revision (IRGBR), an alternative needling system, visualizes anterior-segment tissues around the bleb not visible during needle revision after trabeculectomy. This study determined the safety and efficiency of 5-fluorouracil (5-FU) as an adjunctive anti-metabolite in IRGBR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively analyzed 43 consecutive eyes (40 patients; 14 eyes, primary open-angle; 29 eyes, secondary glaucoma) treated with IRGBR for failing filtering blebs. The patients were divided into two groups. The first one had IRGBR without adjunctive 5-FU subconjunctival injection, and the second one had IRGBR with 5-FU. We performed Kaplan-Meier survival analysis using log-rank tests after 2\u2009years of follow-up and Cox proportional hazards regression model to analyze the dependence of the survival time on predictor variables. Two failure criteria were defined as the need for additional surgery for intraocular pressure (IOP) reduction and the IOP at two consecutive follow-up visits based on definition 1, IOP \u226722\u2009mmHg and definition 2, IOP \u226717\u2009mmHg.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thirty eyes (29 cases) underwent IRGBR with subconjunctival 5-FU injection (group A in the second term) and 13 eyes (11 cases) without 5-FU (group B in the first term). The success rates 24\u2009months after IRGBR were 73.3 and 23.1%, respectively, in groups A and B based on the definition 1 failure and 56.7 and 7.7% based on the definition 2 failure. Complications included transient bleb leaks (group A, 3 eyes; group B, none) and choroidal detachment (group A, 1 eye; group B, none). No use of 5-FU and IOPs \u226710\u2009mmHg 1\u2009week after IRGBR were significant risk factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Adjunctive 5-FU in IRGBR achieved a better success rate for failing trabeculectomy blebs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-021-01843-4","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T22:44:17Z","timestamp":1612824257000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy and safety of 5-fluorouracil in infrared monitor guided bleb revision"],"prefix":"10.1186","volume":"21","author":[{"given":"Rumi","family":"Kawashima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohji","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,8]]},"reference":[{"key":"1843_CR1","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1097\/IJG.0b013e318181283e","volume":"17","author":"RM Feldman","year":"2008","unstructured":"Feldman RM, Tabet RR. Needle revision of filtering blebs. J Glaucoma. 2008;17:594\u2013600.","journal-title":"J Glaucoma"},{"key":"1843_CR2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1159\/000508606","volume":"11","author":"K Matsushita","year":"2020","unstructured":"Matsushita K, Kawashima R, Nishida K. Development of an infrared monitor-guided bleb revision procedure. Case Rep Ophthalmol. 2020;11:234\u201341.","journal-title":"Case Rep Ophthalmol"},{"key":"1843_CR3","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1097\/00061198-200110001-00029","volume":"10","author":"PT Khaw","year":"2001","unstructured":"Khaw PT. Advances in glaucoma surgery: evolution of antimetabolite adjunctive therapy. J Glaucoma. 2001;10:S81\u20134.","journal-title":"J Glaucoma"},{"key":"1843_CR4","first-page":"152","volume":"24","author":"VP Costa","year":"1993","unstructured":"Costa VP, Spaeth GL, Eiferman RA, et al. Wound healing modulation in glaucoma filtration surgery. Ophthalmic Surg. 1993;24:152\u201370.","journal-title":"Ophthalmic Surg"},{"key":"1843_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0002-9394(14)76340-8","volume":"110","author":"RH Ewing","year":"1990","unstructured":"Ewing RH, Stamper RL. Needle revision with and without 5-fluorouracil for the treatment of failed filtering blebs. Am J Ophthalmol. 1990;110:254\u20139.","journal-title":"Am J Ophthalmol"},{"key":"1843_CR6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/IJG.0000000000001226","volume":"28","author":"JS Kim","year":"2019","unstructured":"Kim JS, Kim HJ, Na KI, et al. Comparison of efficacy and safety of bleb needle revision with and without 5-fluorouracil for failing trabeculectomy bleb. J Glaucoma. 2019;28:386\u201391.","journal-title":"J Glaucoma"},{"key":"1843_CR7","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.ophtha.2003.07.009","volume":"111","author":"DC Broadway","year":"2004","unstructured":"Broadway DC, Bloom PA, Bunce C, et al. Needle revision of failing and failed trabeculectomy blebs with adjunctive 5-fluorouracil. Ophthalmology. 2004;111:665\u201373.","journal-title":"Ophthalmology."},{"key":"1843_CR8","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.ophtha.2007.10.023","volume":"115","author":"AP Rotchford","year":"2008","unstructured":"Rotchford AP, King AJ. Needling revision of trabeculectomies bleb morphology and long-term survival. Ophthalmology. 2008;115:1148\u201353.","journal-title":"Ophthalmology."},{"key":"1843_CR9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/IJG.0b013e318170a71c","volume":"18","author":"MS Kapasi","year":"2009","unstructured":"Kapasi MS, Birt CM. The efficacy of 5-fluorouracil bleb needling performed 1 year or more posttrabeculectomy: a retrospective study. J Glaucoma. 2009;18:144\u20138.","journal-title":"J Glaucoma"},{"key":"1843_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/IJG.0000000000000235","volume":"25","author":"L Zheng","year":"2016","unstructured":"Zheng L, Arvind H, Wechsler D. Outcomes: trabeculectomy bleb needle revision with 5-fluorouracil. J Glaucoma. 2016;25:317\u201323.","journal-title":"J Glaucoma"},{"key":"1843_CR11","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0002-9394(01)01232-6","volume":"132","author":"DH Shin","year":"2001","unstructured":"Shin DH, Kim YY, Ginde SY, et al. Risk factors for failure of 5-fluorouracil needling revision for failed conjunctival filtration blebs. Am J Ophthalmol. 2001;132:875\u201380.","journal-title":"Am J Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-01843-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-021-01843-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-01843-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T22:49:08Z","timestamp":1612824548000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-021-01843-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,8]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1843"],"URL":"https:\/\/doi.org\/10.1186\/s12886-021-01843-4","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,8]]},"assertion":[{"value":"2 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Osaka University Graduate School of Medicine. We obtained informed consent from all subjects in the form of opt-out on the Web (sitehttp:\/\/ExternalRef removed).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}